Commentary

Article

State of the Science Summit - Breast and Lung Cancer: Chaired by Anne Favret, MD, and Samantha DiBenedetto, MD

In Partnership With:

State of the Science Summit - Breast and Lung Cancer: Chaired by Anne Favret, MD, and Samantha DiBenedetto, MD.

State of the Science Summit - Breast and Lung Cancer: Chaired by Anne Favret, MD, and Samantha DiBenedetto, MD

Speakers

  • Anne Favret, MD | Virginia Cancer Specialists
  • Samantha DiBenedetto, MD | Virginia Cancer Specialists
  • Anmol Singh, MD | Virginia Cancer Specialists
  • Shruti Tiwari, MD | Virginia Cancer Specialists
  • Igryl S Cordero-Hernandez, MD | Virginia Cancer Specialists

Topics

  • Endocrine-Based Combination Therapies in HR+/HER2- mBC
  • Approaches Beyond CDK 4/6 Inhibitors for mBC
  • Management of HER2+ and HER2-low mBC
  • EGFRm in NSCLC: Adjuvant to Metastatic
  • Neoadjuvant and Adjuvant Immunotherapies in NSCLC
  • Emerging ADCs in Lung Cancer

Interested in virtually attending an IPC event? Click here to register for an upcoming webinar.

Some of the episodes from our podcast, OncLive On Air, are focused on the interviews with faculty conducted at the State of the Science Summits. Click here to listen to our latest episodes!

Related Videos
Erminia Massarelli, MD, PhD, MS
Karen L. Reckamp, MD, MS
Jacob Sands, MD, oncology medical director, International Patient Center, Dana-Farber Cancer Institute; assistant professor, Harvard Medical School
Fred R. Hirsch, MD, PhD, executive director, Center for Thoracic Oncology, The Tisch Cancer Institute at Mount Sinai; Joe Lowe and Louis Price Professor of Medicine (Hematology and Medical Oncology), Icahn School of Medicine at Mount Sinai
Julia Rotow, MD, clinical director, Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute; assistant professor, medicine, Harvard Medical School
Joshua K. Sabari, MD, assistant professor, Department of Medicine, New York University Grossman School of Medicine; director, High Reliability Organization Initiatives, Perlmutter Cancer Center
Alastair Thompson, BSc, MBChB, MD, FRCS
Adam M. Brufsky, MD, PhD, FACP
Sara M. Tolaney, MD, MPH
Leah Backhus, MD, MPH, FACS, professor, University Medical Line, Cardiothoracic Surgery, co-director, Thoracic Surgery Clinical Research Program, associate program director, Thoracic Track, CT Surgery Residency Training Program, Thelma and Henry Doelger Professor of Cardiovascular Surgery, Stanford Medicine; chief, Thoracic Surgery, VA Palo Alto
Related Content
Antonio Passaro, MD, PhD, medical oncologist, Division of Thoracic Oncology, European Institute of Oncology
July 26th 2024

CHMP Recommends Amivantamab Plus Chemo for Pretreated EGFR+ Advanced NSCLC

Martin F. Dietrich, MD, PhD, medical oncologist, Cancer Care Centers of Brevard, The US Oncology Network, assistant professor, internal medicine, the University of Central Florida College of Medicine; Michelle Shiller, DO, cancer liaison physician, medical director, Genetics, assistant medical director, Baylor Scott & White Health in Dallas, medical director, Genomics and Molecular Pathology Services, PathGroup
June 27th 2024

Dietrich and Shiller Dive Into the Importance of Oncology Reflex Testing

Jonathan W. Riess, MD, MS
July 26th 2024

Experts Weigh in on Topic of Frontline Osimertinib Alone or With Chemo in EGFR-Mutant NSCLC

Stephen Liu, MD; Sara A. Hurvitz, MD, FACP; S. Vincent Rajkumar, MD; Sumanta Kumar Pal, MD, FASCO; Shubham Pant, MD, MBBS
May 23rd 2024

Oncology Experts Preview Top Abstracts From the 2024 ASCO Annual Meeting

Adrienne G. Waks, MD, of Dana-Farber Cancer Institute
July 26th 2024

Changes in HER2+ Breast Cancer May Include Tailored Therapy With pCR, Use of T-DXd

Helen J. Ross, MD, of RUSH Cancer Center
July 25th 2024

Atezolizumab Before and After CRT Appears Safe, Effective in Unresectable Stage III NSCLC